Viewing Study NCT05730361


Ignite Creation Date: 2025-12-24 @ 12:17 PM
Ignite Modification Date: 2025-12-27 @ 4:06 PM
Study NCT ID: NCT05730361
Status: UNKNOWN
Last Update Posted: 2023-02-15
First Post: 2023-02-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase Ib Clinical Study on the Safety, the Tolerability, the Pharmacokinetics and the Efficacy of ScTIL Injection (Gene Modified Tumor Infiltrating Lymphocytes) Alone and in Combination With B Lymphocyte Adjuvant in the Treatment of Digestive System Malignant Solid Tumors
Sponsor: Peking University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module